Latest Breaking News On - ஜொனாதன் பிர்ட் - Page 1 : comparemela.com

eureKARE launches with $60 million to build and finance next generation biotech companies in Europe B innovation eureKARE accompanied by a hig May 2021: eureKARE ( the Company ), a pioneering new company focused on financing and building next generation biotechnology companies in the disruptive fields of the microbiome and synthetic biology, today announces its launch with a $60 million Series A financing. The financing was supported by high-net worth investors and family offices. eureKARE is focused on two emerging and cutting-edge fields of research that have the potential to disrupt and revolutionize the life sciences industry: the microbiome and synthetic biology. Up to 90% of all diseases can be linked to the dysfunction and imbalance of the microbiome with the field forecast to reach $1.6 billion by 2028 at a CAGR of 21%. Synthetic biology, which comprises gene and cell therapy and industrial applications such as data storage and bioproduction, has seen huge advances

Region flamandeFrance generalAmber fennellCarina jursKostenloser wertpapierhandelMelissa gardinerJonathan birtAlexandre mouradianMarina shapochnikConsilium strategic communicationsScientific advisory boardChief executive officerStellate therapeuticsOmne possibileAdvisory boardNon alcoholic fatty liver disease